Conclusion As the multi-hit hypothesis holds, combining the therapeutic approaches of GLP-1 agonists with resmetirom seems like a promising strategy by targeting the multifaceted pathophysiology of MASH, which may lead to improved patient outcomes
Hero molecule emphasis: PDRN (MITF downregulation, anti-melanogenesis), GHK-Cu (dermal remodeling), Centella (post-procedure barrier protection in pigment-sensitive skin)
Hypoallergenic supplements are typically formulated without ingredients known to be common food allergens, such as milk, fish, shellfish, eggs and nuts, and/or gluten , and certain artificial coloring agents, and fillers
Originally developed to manage type 2 diabetes, GLP-1s have gained recognition for their efficacy in promoting weight loss by mimicking the actions of the glucagon-like peptide-1 hormone, which regulates appetite and insulin secretion
Corbin KD, Driscoll KA, Pratley RE, Smith SR, Maahs DM, Mayer-Davis EJ (2018) Obesity in type 1 diabetes: pathophysiology, clinical impact, and mechanisms
Data We process personal data under UK GDPR